The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Flow cytometric analysis of human PD-L1 (CD274) expression on activated human lymphocytes. Human peripheral blood mononuclear cells were stimulated with Phytohemagglutinin (PHA) for 3 days and were stained with either Mouse IgG2b, κ Isotype Control (Cat. No. 555058; dotted line histogram) or PE Mouse Anti-Human PD-L1 (CD274) antibody (Cat. No. 568079/568080; solid line histogram). The fluorescence histogram showing the expression of CD274 (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of activated viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of human PD-L1 (CD274) expression on activated human lymphocytes. Human peripheral blood mononuclear cells were stimulated with Phytohemagglutinin (PHA) for 3 days and were stained with either Mouse IgG2b, κ Isotype Control (Cat. No. 555058; dotted line histogram) or PE Mouse Anti-Human PD-L1 (CD274) antibody (Cat. No. 568079/568080; solid line histogram). The fluorescence histogram showing the expression of CD274 (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of activated viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Flow cytometric analysis of human PD-L1 (CD274) expression on activated human lymphocytes. Human peripheral blood mononuclear cells were stimulated with Phytohemagglutinin (PHA) for 3 days and were stained with either Mouse IgG2b, κ Isotype Control (Cat. No. 555058; dotted line histogram) or PE Mouse Anti-Human PD-L1 (CD274) antibody (Cat. No. 568079/568080; solid line histogram). The fluorescence histogram showing the expression of CD274 (or Ig Isotype control staining) was derived from gated events with the forward and side light-scatter characteristics of activated viable lymphocytes. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 29E.2A3 monoclonal antibody can reportedly bind to Alexa Fluor™ 700 antibody conjugates during multicolor immunofluorescence staining experiments. This interaction may be circumvented by sequentially staining with the 29E.2A3 antibody first, followed by a wash step, and then further staining with an Alexa Fluor™ 700 antibody conjugate of interest.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
The 29E.2A3 monoclonal antibody specifically recognizes Programmed cell death 1 ligand 1 (PDCD1 ligand 1, PDCD1L1, PDCD1LG1) which is also known as Programmed death ligand 1 (PD-L1 or PDL1) as well as CD274, or B7 homolog 1 (B7-H1, B7H1). PD-L1 (CD274) and PD-L2 (CD273) are type I transmembrane glycoproteins that belong to the B7 family within the Ig gene superfamily and serve as ligands for CD279 (Program Death 1/PD-1). PD-L1 (CD274) is expressed on antigen-presenting cells including activated monocytes, macrophages, and dendritic cells (DCs) as well as activated T cells, B cells, NK cells, and keratinocytes. PD-L1 (CD274) is also variably expressed on placental trophoblasts, myocardial endothelium, cortical thymic epithelial cells, and tumor cells. PD-L1-mediated signaling through PD-1 regulates T cell responses important for providing protective immunity while maintaining peripheral tolerance. This immune signaling checkpoint may also suppress antitumor immune responses and prevent tumor rejection. The 29E.2A3 antibody reportedly blocks PD-L1 (CD274) binding to CD279 (PD-1) and can enhance the proliferation and cytokine production of activated T cells.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.